Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
BMJ Open|January 8, 2015
Estimates of price and income elasticity in Greece. Greek debt crisis transforming cigarettes into a luxury good: an econometric approachFilippos Tarantilis, Kostas Athanasakis, Dimitris Zavras, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 11, 2016
How peptide technology has improved costs and outcomes in patients with heart failureKostas Athanasakis, Ioli Arista, Thanos Balasopoulos, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|December 30, 2008
Cost-minimisation analysis of oral anticoagulant therapy monitoring methods: the case for prothrombin time self-monitoringMary Geitona, Mark Hollandezos, Kyriakos Souliotis, et al.
Journal of Hypertension|December 14, 2011
A cost-utility analysis of hypertension treatment in Greece: assessing the impact of age, sex and smoking status, on outcomesKostas Athanasakis, Kyriakos Souliotis, Yannis Tountas, et al.
Clinical Drug Investigation|September 20, 2015
Cost-effectiveness of apixaban vs. other new oral anticoagulants for the prevention of stroke: an analysis on patients with non-valvular atrial fibrillation in the Greek healthcare settingKostas Athanasakis, Eleftheria Karampli, Dimitrios Tsounis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|July 17, 2012
Management of atrial fibrillation in the Greek healthcare settingEleftheria Karampli, Kostas Athanasakis, Markos Ollandezos, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 12, 2024
Predictive Performance of Artificial intelligence Models on Heart and Lung Posttransplant Health Outcomes: A Systematic ReviewGeorge C Sargiotis, Theodoros N Sergentanis, Elpida Pavi, et al.
Expert Review of Molecular Diagnostics|March 1, 2025
Comprehensive genomic profiling: a public health system perspectiveThemistoklis Paraskevas, Michail Papapanou, Theodoros N Sergentanis, et al.
The American Journal of Managed Care|April 9, 2011
Abolishing coinsurance for oral antihyperglycemic agents: effects on social insurance budgetsKostas Athanasakis, Anastasis G Skroumpelos, Vassiliki Tsiantou, et al.
Clinical Therapeutics|July 24, 2012
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in GreeceKostas Athanasakis, Michael Igoumenidis, Eleftheria Karampli, et al.
Pageof 8